NASDAQ$DH
Definitive Healthcare Corp · Q1 2026 earnings
Q1 2026 earnings · · Investor relations
Briefing
Definitive Healthcare reported Q1 2026 revenue of $55.9M and a net loss attributable to the company of $138.6M.
Q1 2026 revenue was $55.9 million (-6% YoY) as subscription revenue declined $3.7 million partially offset by professional services. Net loss attributable to Definitive Healthcare was $138.6 million, including substantial non-cash and interest-related items; loss before tax was $195.8 million.
- Revenue $55.9M (-6% YoY).
- Net loss attributable to DH $(138.6)M.
- Subscription revenue pressure from customer churn.
- Data and analytics platform repositioning in MD&A.
Headline financials
Revenue & EPS history
Definitive Healthcare · Revenue · Quarterly
$55.9M
Forward guidance
Healthcare data SaaS discusses ARR trends, cost actions, and debt structure without quarterly EPS guide.
Tailwinds
- Professional services revenue grew modestly.
- Cost reduction and focus on enterprise customers.
Headwinds
- Subscription revenue decline and large GAAP net loss.
- Leverage and interest burden on capital structure.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 18 quarterly earnings reports · overlaid with Q1 2026
-3.2%
Avg return
Earnings day
-5.7%
Avg return
5 days after
-5.8%
Avg return
30 days after
39%
7 / 18 earnings
Positive
+31.7%
Q1 2025
Best reaction
-34.3%
Q4 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -2.2% | -2.0% | -5.2% | |
| Q4 2025 | -8.6% | -12.9% | -25.0% | |
| Q3 2025 | +11.9% | +2.6% | -6.4% | |
| Q1 2025 | +31.7% | +21.4% | +33.1% | |
| Q4 2024 | -34.3% | -43.7% | -40.2% | |
| Q3 2024 | -1.4% | +6.3% | +8.4% | |
| Q2 2024 | -1.4% | +5.1% | +21.6% | |
| Q1 2024 | -27.1% | -27.5% | -22.9% | |
| Q4 2023 | +2.3% | -4.2% | -13.3% | |
| Q3 2023 | +27.5% | +29.5% | +49.5% | |
| Q2 2023 | -4.0% | -6.2% | -21.2% | |
| Q1 2023 | +0.9% | -3.7% | +7.9% | |
| Q4 2022 | +3.5% | -1.6% | -11.5% | |
| Q3 2022 | -25.0% | -29.7% | -14.5% | |
| Q2 2022 | -16.3% | -18.6% | -35.7% | |
| Q1 2022 | -17.5% | -31.3% | -19.4% | |
| Q4 2021 | +7.6% | +13.6% | +14.0% | |
| Q3 2021 | -5.8% | +0.2% | -23.3% | |
| Q2 2021 | — | — | — | |
| Q1 2021 | — | — | — | |
| Q4 2020 | — | — | — | |
| Q3 2020 | — | — | — | |
| Q2 2020 | — | — | — | |
| Q1 2020 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro